Rocky Mountain Sarcoma Symposium

  03 Apr 2025 - 03 Apr 2025

   Boulder, CO, United States

conference-img

Rocky Mountain Sarcoma Symposium

03 Apr 2025

 - 

03 Apr 2025

Boulder, CO, United States



The emphasis of the 2025 program is on clinical treatment and clinical trial updates in multidisciplinary sarcoma care. The symposium will include an impressive lineup of lecturers from the University of Colorado as well as nationally-known guest lecturers.

Participants will be able to: Identify treatment protocols for pediatric and AYA soft tissue sarcoma; understand surgical options in local control for pediatric and AYA bone sarcoma; understand hypofractionated RT regimens and potential concerns with wound healing and late toxicity; understand current systemic treatment options for sarcoma and evolving evidence for immunotherapy check point inhibitors and latest approved cell based therapy strategies; understand current treatments for GIST

International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026


International Cancer Conference

On: 15 Oct 2026

-

15 Oct 2026


Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

On: 20 Oct 2026

-

20 Oct 2026


International Conference on Healthcare Innovation and Medical Sciences (ICHIMS)

On: 15 Nov 2026

-

15 Nov 2026


International Conference on Medical, Biological and Pharmaceutical Sciences

On: 15 Nov 2026

-

15 Nov 2026


Summer Global Neuroscience & Neurology Symposium

On: 15 Nov 2026

-

15 Nov 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Big Comeback for Myeloma Drug; DIY Cancer Therapy; Gut Clues to Bladder Cancer

2.

EVP Beats Cisplatin for Resectable MIBC

3.

For elderly, unfit patients, the all-oral AML regimen shows promise.

4.

Study sets benchmark for treatment of advanced cervical cancer

5.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot